PMID- 19321411 OWN - NLM STAT- MEDLINE DCOM- 20090707 LR - 20181201 IS - 1607-551X (Print) IS - 1607-551X (Linking) VI - 25 IP - 2 DP - 2009 Feb TI - Oxcarbazepine-induced Stevens-Johnson syndrome: a case report. PG - 82-6 LID - 10.1016/S1607-551X(09)70045-2 [doi] AB - Although carbamazepine (CBZ) is the most common cause of Stevens-Johnson syndrome (SJS), a new anticonvulsant, oxcarbazepine, which is structurally related to carbamazepine, has been shown to induce SJS, although extremely rarely. Recently, a strong association was found between human leukocyte antigen (HLA) B*1502 and CBZ-induced SJS/TEN in a Han Chinese population. Here, we report a case with SJS, which was induced by oxcarbazepine. HLA genotyping in the patient showed HLA-B*1518/B*4001. HLA-B*1518 is a HLA-B15 variant. The genetic significance of HLA-B*1518 in association with oxcarbazepine-induced SJS needs to be further studied. FAU - Lin, Lung-Chang AU - Lin LC AD - Department of Pediatrics, Kaohsiung Medical University Hospital, Kaohsiung, Taiwan. FAU - Lai, Ping-Chin AU - Lai PC FAU - Yang, Sheau-Fang AU - Yang SF FAU - Yang, Rei-Cheng AU - Yang RC LA - eng PT - Case Reports PT - Journal Article PL - China (Republic : 1949- ) TA - Kaohsiung J Med Sci JT - The Kaohsiung journal of medical sciences JID - 100960562 RN - 0 (Anticonvulsants) RN - 0 (HLA-B Antigens) RN - 0 (HLA-B15 Antigen) RN - 33CM23913M (Carbamazepine) RN - VZI5B1W380 (Oxcarbazepine) SB - IM MH - Anticonvulsants/*adverse effects MH - Carbamazepine/adverse effects/*analogs & derivatives MH - Child MH - Genotype MH - HLA-B Antigens/genetics MH - HLA-B15 Antigen MH - Humans MH - Male MH - Oxcarbazepine MH - Stevens-Johnson Syndrome/*chemically induced/etiology/genetics/pathology EDAT- 2009/03/27 09:00 MHDA- 2009/07/08 09:00 CRDT- 2009/03/27 09:00 PHST- 2009/03/27 09:00 [entrez] PHST- 2009/03/27 09:00 [pubmed] PHST- 2009/07/08 09:00 [medline] AID - S1607-551X(09)70045-2 [pii] AID - 10.1016/S1607-551X(09)70045-2 [doi] PST - ppublish SO - Kaohsiung J Med Sci. 2009 Feb;25(2):82-6. doi: 10.1016/S1607-551X(09)70045-2.